Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J. Am. Coll. Cardiol. 76, 2982–3021 (2020).
Article PubMed PubMed Central Google Scholar
Eeckhout, E. & Kern, M. J. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur. Heart J. 22, 729–739 (2001).
Article CAS PubMed Google Scholar
Heusch, G. The coronary circulation as a target of cardioprotection. Circ. Res. 118, 1643–1658 (2016).
Article CAS PubMed Google Scholar
Heusch, G. Coronary microvascular obstruction: the new frontier in cardioprotection. Basic. Res. Cardiol. 114, 45 (2019).
Niccoli, G. et al. Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role. J. Cardiovasc. Med. 17, 382–391 (2016).
de Waha, S. et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur. Heart J. 38, 3502–3510 (2017).
Niccoli, G., Scalone, G., Lerman, A. & Crea, F. Coronary microvascular obstruction in acute myocardial infarction. Eur. Heart J. 37, 1024–1033 (2016).
Niccoli, G. et al. Optimized treatment of ST-elevation myocardial infarction. Circ. Res. 125, 245–258 (2019).
Article CAS PubMed Google Scholar
Heusch, G. & Gersh, B. J. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur. Heart J. 38, 774–784 (2017).
Heusch, G. Myocardial ischaemia–reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol. 17, 773–789 (2020).
Reffelmann, T. & Kloner, R. A. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic. Res. Cardiol. 101, 359–372 (2006).
Inserte, J., Hernando, V. & Garcia-Dorado, D. Contribution of calpains to myocardial ischaemia/reperfusion injury. Cardiovasc. Res. 96, 23–31 (2012).
Article CAS PubMed Google Scholar
Scarabelli, T. et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104, 253–256 (2001).
Article CAS PubMed Google Scholar
Kleinbongard, P. & Heusch, G. A fresh look at coronary microembolization. Nat. Rev. Cardiol. 19, 265–280 (2022).
Bekkers, S. C., Yazdani, S. K., Virmani, R. & Waltenberger, J. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J. Am. Coll. Cardiol. 55, 1649–1660 (2010).
Kleinbongard, P. et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ. Res. 108, 344–352 (2011).
Article CAS PubMed Google Scholar
Heusch, G. et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation 120, 1822–1836 (2009).
Stakos, D. A. et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur. Heart J. 36, 1405–1414 (2015).
Article CAS PubMed PubMed Central Google Scholar
Gick, M. et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 112, 1462–1469 (2005).
Yoshino, S. et al. Single nucleotide polymorphisms associated with abnormal coronary microvascular function. Coron. Artery Dis. 25, 281–289 (2014).
Article PubMed PubMed Central Google Scholar
Heusch, G., Bøtker, H. E., Ferdinandy, P. & Schulz, R. Primordial non-responsiveness: a neglected obstacle to cardioprotection. Eur. Heart J. 44, 1687–1689 (2023).
Niccoli, G. et al. Protective effect of pre-infarction angina on microvascular obstruction after primary percutaneous coronary intervention is blunted in humans by cardiovascular risk factors. Circ. J. 78, 1935–1941 (2014).
Niccoli, G. et al. Ethanol abolishes ischemic preconditioning in humans. J. Am. Coll. Cardiol. 51, 271–275 (2008).
Article CAS PubMed Google Scholar
Ferdinandy, P. et al. Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning. Pharmacol. Rev. 75, 159–216 (2023).
Article CAS PubMed PubMed Central Google Scholar
Gibson, C. M. et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101, 125–130 (2000).
Article CAS PubMed Google Scholar
Iwakura, K. et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 41, 1–7 (2003).
Article CAS PubMed Google Scholar
Lind, L. et al. The impairment in endothelial function induced by non-esterified fatty acids can be reversed by insulin. Clin. Sci. 99, 169–174 (2000).
Gresele, P. et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J. Am. Coll. Cardiol. 41, 1013–1020 (2003).
Article CAS PubMed Google Scholar
Hayakawa, H. & Raij, L. Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension. J. Hypertens. 17, 611–619 (1999).
Article CAS PubMed Google Scholar
Stapleton, P. A., Goodwill, A. G., James, M. E., D’Audiffret, A. C. & Frisbee, J. C. Differential impact of familial hypercholesterolemia and combined hyperlipidemia on vascular wall and network remodeling in mice. Microcirculation 17, 47–58 (2010).
Article CAS PubMed PubMed Central Google Scholar
Kirma, C. et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ. J. 72, 716–721 (2008).
Ito, H. et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 93, 1993–1999 (1996).
Article CAS PubMed Google Scholar
Iwakura, K. et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J. Am. Coll. Cardiol. 38, 472–477 (2001).
Article CAS PubMed Google Scholar
Eitel, I. et al. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging. Am. Heart J. 159, 882–890 (2010).
Article CAS PubMed Google Scholar
Tarantini, G. et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J. Am. Coll. Cardiol. 46, 1229–1235 (2005).
Durante, A. et al. Identification of high-risk patients after ST-segment-elevation myocardial infarction: comparison between angiographic and magnetic resonance parameters. Circ. Cardiovasc. Imaging 10, e005841 (2017).
van ‘t Hof, A. W. et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 97, 2302–2306 (1998).
Vergallo, R. et al. Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Minerva Cardiol. Angiol. 71, 421–430 (2023).
Porto, I. et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 114, 662–669 (2006).
Comments (0)